162 related articles for article (PubMed ID: 36175559)
1. High PSQI score is associated with the development of dyskinesia in Parkinson's disease.
Tang X; Yang J; Zhu Y; Gong H; Sun H; Chen F; Guan Q; Yu L; Wang W; Zhang Z; Li L; Ma G; Wang X
NPJ Parkinsons Dis; 2022 Sep; 8(1):124. PubMed ID: 36175559
[TBL] [Abstract][Full Text] [Related]
2. Poor nighttime sleep is positively associated with dyskinesia in Parkinson's disease patients.
Mao CJ; Yang YP; Chen JP; Wang F; Chen J; Zhang JR; Zhang HJ; Zhuang S; Xiong YT; Gu CC; Yuan W; Huang JY; Fay A; Zhong CK; Liu CF
Parkinsonism Relat Disord; 2018 Mar; 48():68-73. PubMed ID: 29305084
[TBL] [Abstract][Full Text] [Related]
3. [The clinical efficacy of the stratification medical treatment based on the risk estimation of motor complications in Parkinson's disease].
Wan Y; Xiao RQ; Zhao JH; Zhang Y; Gan J; Wu N; Song L; Li L; Qi C; Chen W; Wang XJ; Liu ZG
Zhonghua Yi Xue Za Zhi; 2022 Feb; 102(7):491-498. PubMed ID: 35184502
[No Abstract] [Full Text] [Related]
4. Factors Associated With Dyskinesia in Parkinson's Disease in Mainland China.
Zhou X; Guo J; Sun Q; Xu Q; Pan H; Yu R; Tan J; Yan X; Tang B; Fang L
Front Neurol; 2019; 10():477. PubMed ID: 31164859
[No Abstract] [Full Text] [Related]
5. Measurement of serum cystatin C: A valuable tool for evaluating dyskinesia in Parkinson's disease.
Dong X; Zheng D; Nao J
Neurosci Lett; 2019 Jul; 705():172-176. PubMed ID: 31054924
[TBL] [Abstract][Full Text] [Related]
6. Study on the Clinical Features of Parkinson's Disease With Probable Rapid Eye Movement Sleep Behavior Disorder.
Long K; Wan C; Xiang Y; Liu J; Xu Q; Sun Q; Wang Z; Tian Y; Fang L; Yang Y; Yan X; Tang B; Guo J
Front Neurol; 2020; 11():979. PubMed ID: 33041969
[No Abstract] [Full Text] [Related]
7. Predictors of motor complications in early Parkinson's disease: A prospective cohort study.
Kelly MJ; Lawton MA; Baig F; Ruffmann C; Barber TR; Lo C; Klein JC; Ben-Shlomo Y; Hu MT
Mov Disord; 2019 Aug; 34(8):1174-1183. PubMed ID: 31283854
[TBL] [Abstract][Full Text] [Related]
8. Does gender differences have a role in determining sleep quality in Parkinson's disease?
Mahale R; Yadav R; Pal PK
Acta Neurol Belg; 2021 Aug; 121(4):1001-1007. PubMed ID: 32946048
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia is associated with non-motor symptoms in Han Chinese patients with Parkinson's Disease: a cross-sectional study.
Liu QW; Mao CJ; Lu ZH; Shi RF; Zhang YC; Zhao P; Liu CF
BMC Geriatr; 2023 Aug; 23(1):494. PubMed ID: 37587447
[TBL] [Abstract][Full Text] [Related]
10. Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: an open-label study.
Kim JM; Chung SJ; Kim JW; Jeon BS; Singh P; Thierfelder S; Ikeda J; Bauer L;
BMC Neurol; 2015 Feb; 15():17. PubMed ID: 25879416
[TBL] [Abstract][Full Text] [Related]
11. Risk thresholds of levodopa dose for dyskinesia in Chinese patients with Parkinson's disease: a pilot study.
Liu G; Chen H; Su D; Wang D; Zhang M; Wang X; Wang Z; Yang Y; Jiang Y; Ma H; Feng T
Neurol Sci; 2020 Jan; 41(1):111-118. PubMed ID: 31446577
[TBL] [Abstract][Full Text] [Related]
12. Effect of onset age on the levodopa threshold dosage for dyskinesia in Parkinson's disease.
Zhang Z; Liu G; Wang D; Chen H; Su D; Kou W; Zhao J; Wang X; Wang Z; Ma H; Feng T
Neurol Sci; 2022 May; 43(5):3165-3174. PubMed ID: 34853899
[TBL] [Abstract][Full Text] [Related]
13. Sleep disturbances in Taiwanese patients with Parkinson's disease.
Lin YY; Chen RS; Lu CS; Huang YZ; Weng YH; Yeh TH; Lin WY; Hung J
Brain Behav; 2017 Oct; 7(10):e00806. PubMed ID: 29075566
[TBL] [Abstract][Full Text] [Related]
14. Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-Up.
Chaudhuri KR; Antonini A; Pahwa R; Odin P; Titova N; Thakkar S; Snedecor SJ; Hegde S; Alobaidi A; Parra JC; Zadikoff C; Bergmann L; Standaert DG
J Parkinsons Dis; 2022; 12(7):2071-2083. PubMed ID: 35964203
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors and Metabolism of Different Brain Regions by Positron Emission Tomography in Parkinson Disease with Disabling Dyskinesia.
Wei H; Zhou Y; Zhao J; Zhan L
Curr Neurovasc Res; 2019; 16(4):310-320. PubMed ID: 31622205
[TBL] [Abstract][Full Text] [Related]
16. Association of sleep disturbance and freezing of gait in Parkinson disease: prevention/delay implications.
Tang X; Yu L; Yang J; Guo W; Liu Y; Xu Y; Wang X
J Clin Sleep Med; 2021 Apr; 17(4):779-789. PubMed ID: 33231167
[TBL] [Abstract][Full Text] [Related]
17. Poor sleep quality is associated with cognitive, mobility, and anxiety disability that underlie freezing of gait in Parkinson's disease.
de Almeida FO; Ugrinowitsch C; Brito LC; Milliato A; Marquesini R; Moreira-Neto A; Barbosa ER; Horak FB; Mancini M; Silva-Batista C
Gait Posture; 2021 Mar; 85():157-163. PubMed ID: 33578308
[TBL] [Abstract][Full Text] [Related]
18. Radiomics and Hybrid Models Based on Machine Learning to Predict Levodopa-Induced Dyskinesia of Parkinson's Disease in the First 6 Years of Levodopa Treatment.
Luo Y; Chen H; Gui M
Diagnostics (Basel); 2023 Jul; 13(15):. PubMed ID: 37568874
[TBL] [Abstract][Full Text] [Related]
19. Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.
Warren Olanow C; Kieburtz K; Rascol O; Poewe W; Schapira AH; Emre M; Nissinen H; Leinonen M; Stocchi F;
Mov Disord; 2013 Jul; 28(8):1064-71. PubMed ID: 23630119
[TBL] [Abstract][Full Text] [Related]
20. Does Late Levodopa Administration Delay the Development of Dyskinesia in Patients with De Novo Parkinson's Disease?
Chung SJ; Yoo HS; Lee HS; Jeong HE; Kim SJ; Oh JS; Kim JS; Sohn YH; Lee PH
CNS Drugs; 2018 Oct; 32(10):971-979. PubMed ID: 30027399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
